Gland Pharma Limited reports a change in its board or management
In short
Gland Pharma Limited said Mr Ajay Sahni has been appointed President of Phixen SAS, its wholly-owned step-down subsidiary, effective November 30, 2026. In simple terms, Gland Pharma is putting a new leader in charge of Phixen SAS. No figures, scheme names, or closing dates are given in the announcement.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.